Kymera Therapeutics, Inc.KYMRNASDAQ
Loading
Current Ratio Over TimeElevated
Percentile Rank100
3Y CAGR+21.2%
5Y CAGR+30.8%
Studio
Year-over-Year Change

Current ratio (current assets / current liabilities)

3Y CAGR
+21.2%/yr
vs -9.9%/yr prior
5Y CAGR
+30.8%/yr
Recent deceleration
Acceleration
+31.1pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.8x
Strong expansion
Streak
2 yr
Consecutive growthElevated
PeriodValueYoY Change
202510.47+39.0%
20247.53+59.2%
20234.73-19.5%
20225.88+20.6%
20214.88+78.4%
20202.73+1.8%
20192.69-69.9%
20188.92-